Teza Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $227K | Sell |
4,138
-6,086
| -60% | -$335K | 0.17% | 242 |
|
|
2025
Q1 | $723K | Buy |
+10,224
| New | +$723K | 0.33% | 87 |
|
|
2024
Q4 | – | Sell |
-8,833
| Closed | -$621K | – | 527 |
|
|
2024
Q3 | $621K | Buy |
+8,833
| New | +$621K | 0.07% | 332 |
|
|
2023
Q3 | – | Sell |
-4,430
| Closed | -$384K | – | 601 |
|
|
2023
Q2 | $384K | Buy |
4,430
+1,754
| +66% | +$152K | 0.06% | 343 |
|
|
2023
Q1 | $260K | Buy |
+2,676
| New | +$260K | 0.06% | 411 |
|
|
2022
Q4 | – | Sell |
-4,162
| Closed | -$353K | – | 585 |
|
|
2022
Q3 | $353K | Buy |
+4,162
| New | +$353K | 0.07% | 377 |
|
|
2021
Q2 | – | Sell |
-6,716
| Closed | -$507K | – | 559 |
|
|
2021
Q1 | $507K | Buy |
6,716
+476
| +8% | +$35.9K | 0.1% | 268 |
|
|
2020
Q4 | $547K | Buy |
+6,240
| New | +$547K | 0.31% | 111 |
|
|
2020
Q3 | – | Sell |
-3,121
| Closed | -$385K | – | 391 |
|
|
2020
Q2 | $385K | Buy |
+3,121
| New | +$385K | 0.09% | 338 |
|
|
2017
Q2 | – | Sell |
-8,545
| Closed | -$750K | – | 49 |
|
|
2017
Q1 | $750K | Buy |
+8,545
| New | +$750K | 0.22% | 151 |
|